Search by Drug Name or NDC
NDC 54838-0209-70 Siltussin DM 10; 100 mg/5mL; mg/5mL Details
Siltussin DM 10; 100 mg/5mL; mg/5mL
Siltussin DM is a ORAL LIQUID in the HUMAN OTC DRUG category. It is labeled and distributed by Lannett Company, Inc.. The primary component is DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN.
MedlinePlus Drug Summary
Dextromethorphan is used to temporarily relieve cough caused by the common cold, the flu, or other conditions. Dextromethorphan will relieve a cough but will not treat the cause of the cough or speed recovery. Dextromethorphan is in a class of medications called antitussives. It works by decreasing activity in the part of the brain that causes coughing.
Related Packages: 54838-0209-70Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Dextromethorphan
Guaifenesin is used to relieve chest congestion. Guaifenesin may help control symptoms but does not treat the cause of symptoms or speed recovery. Guaifenesin is in a class of medications called expectorants. It works by thinning the mucus in the air passages to make it easier to cough up the mucus and clear the airways.
Related Packages: 54838-0209-70Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Guaifenesin
Product Information
NDC | 54838-0209 |
---|---|
Product ID | 54838-209_39e6fbaa-ce27-41ba-bb09-e86e363da87f |
Associated GPIs | 43997002521220 |
GCN Sequence Number | 016414 |
GCN Sequence Number Description | guaifenesin/dextromethorphan SYRUP 100-10MG/5 ORAL |
HIC3 | B3T |
HIC3 Description | NON-OPIOID ANTITUSSIVE AND EXPECTORANT COMBINATION |
GCN | 53495 |
HICL Sequence Number | 000223 |
HICL Sequence Number Description | GUAIFENESIN/DEXTROMETHORPHAN HBR |
Brand/Generic | Generic |
Proprietary Name | Siltussin DM |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | Guaifenesin and Dextromethorphan Hydrobromide |
Product Type | HUMAN OTC DRUG |
Dosage Form | LIQUID |
Route | ORAL |
Active Ingredient Strength | 10; 100 |
Active Ingredient Units | mg/5mL; mg/5mL |
Substance Name | DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN |
Labeler Name | Lannett Company, Inc. |
Pharmaceutical Class | Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Ant |
DEA Schedule | n/a |
Marketing Category | OTC MONOGRAPH FINAL |
Application Number | part341 |
Listing Certified Through | n/a |
Package
Package Images

NDC 54838-0209-70 (54838020970)
NDC Package Code | 54838-209-70 |
---|---|
Billing NDC | 54838020970 |
Package | 237 mL in 1 BOTTLE, PLASTIC (54838-209-70) |
Marketing Start Date | 1992-09-05 |
NDC Exclude Flag | N |
Pricing Information | |
Price Per Unit | 0.03072 |
Pricing Unit | ML |
Effective Date | 2023-12-20 |
NDC Description | SILTUSSIN DM COUGH SYRUP |
Pharmacy Type Indicator | C/I |
OTC | Y |
Explanation Code | 4, 5 |
Classification for Rate Setting | G |
As of Date | 2024-02-21 |
Standard Product Labeling (SPL)/Prescribing Information SPL 7402358e-8234-472f-aa6d-cee9550662f8 Details
SPL UNCLASSIFIED SECTION
SPL UNCLASSIFIED SECTION
SPL UNCLASSIFIED SECTION
Warnings
Do not use if you are now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric or emotional conditions, or Parkinson’s disease), or for 2 weeks after stopping the MAOI drug. If you do not know if your prescription drug contains an MAOI, ask a doctor or pharmacist before taking this product.
Ask a doctor before use if you have
Stop use and ask a doctor if
SPL UNCLASSIFIED SECTION
Directions
SPL UNCLASSIFIED SECTION
SPL UNCLASSIFIED SECTION
INGREDIENTS AND APPEARANCE
SILTUSSIN DM
guaifenesin and dextromethorphan hydrobromide liquid |
|||||||||||||||||||||||||
|
|||||||||||||||||||||||||
|
|||||||||||||||||||||||||
|
|||||||||||||||||||||||||
|
|||||||||||||||||||||||||
|
|||||||||||||||||||||||||
|
Labeler - Lannett Company, Inc. (002277481) |